Gilead Sciences Inc.

GILD NAS
Pharmaceuticals
Foster City, CA
2016 Revenue (US$ Millions)$30,390
Revenue Growth (%)-6.89%
2015 Revenue (US$ Millions)$32,639
Net Income (US$ Millions)$13,501
Common Shares Outstanding (Millions)1,310.00
Earnings Per Share (US$)$9.94
Price to Earnings Ratio10.15
Total Equity (US$ Millions)$18,887
Return on Equity (%)72.84%
Long Term Debt (US$ Millions)$26,346
Debt to Equity Ratio (%)1.39%
Market Capitalization (US$ Millions)$93,809
Total Assets (US$ Millions)$56,977
Current Assets (US$ Millions)$20,445
Inventories (US$ Millions)$1,587
Current Liabilities (US$ Millions)$9,219
Cost Of Goods Sold (US$ Millions)$4,261
Asset Turnover0.56
Inventory Turnover2.41